Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Mapping Subpopulations of Cancer Cell-Derived Extracellular Vesicles and Particles by Nano-Flow Cytometry.

Choi D, Montermini L, Jeong H, Sharma S, Meehan B, Rak J.

ACS Nano. 2019 Sep 24;13(9):10499-10511. doi: 10.1021/acsnano.9b04480. Epub 2019 Sep 10.

PMID:
31469961
2.

Oncogenic Regulation of Extracellular Vesicle Proteome and Heterogeneity.

Choi D, Spinelli C, Montermini L, Rak J.

Proteomics. 2019 Jan;19(1-2):e1800169. doi: 10.1002/pmic.201800169. Epub 2019 Jan 4. Review.

PMID:
30561828
3.

Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.

Spinelli C, Montermini L, Meehan B, Brisson AR, Tan S, Choi D, Nakano I, Rak J.

J Extracell Vesicles. 2018 Jul 17;7(1):1490144. doi: 10.1080/20013078.2018.1490144. eCollection 2018.

4.

The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.

Choi D, Montermini L, Kim DK, Meehan B, Roth FP, Rak J.

Mol Cell Proteomics. 2018 Oct;17(10):1948-1964. doi: 10.1074/mcp.RA118.000644. Epub 2018 Jul 13.

5.

Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles.

Chennakrishnaiah S, Meehan B, D'Asti E, Montermini L, Lee TH, Karatzas N, Buchanan M, Tawil N, Choi D, Divangahi M, Basik M, Rak J.

J Thromb Haemost. 2018 Sep;16(9):1800-1813. doi: 10.1111/jth.14222. Epub 2018 Aug 16.

PMID:
29971917
6.

Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras.

Lee TH, Chennakrishnaiah S, Meehan B, Montermini L, Garnier D, D'Asti E, Hou W, Magnus N, Gayden T, Jabado N, Eppert K, Majewska L, Rak J.

Oncotarget. 2016 Aug 9;7(32):51991-52002. doi: 10.18632/oncotarget.10627.

7.

PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.

Fang Y, Garnier D, Lee TH, D'Asti E, Montermini L, Meehan B, Rak J.

Angiogenesis. 2016 Jan;19(1):25-38. doi: 10.1007/s10456-015-9486-1. Epub 2015 Sep 15.

PMID:
26374632
8.

Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content.

Montermini L, Meehan B, Garnier D, Lee WJ, Lee TH, Guha A, Al-Nedawi K, Rak J.

J Biol Chem. 2015 Oct 2;290(40):24534-46. doi: 10.1074/jbc.M115.679217. Epub 2015 Aug 13.

9.

An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum.

Das J, Ivanov I, Montermini L, Rak J, Sargent EH, Kelley SO.

Nat Chem. 2015 Jul;7(7):569-75. doi: 10.1038/nchem.2270. Epub 2015 Jun 1.

PMID:
26100805
10.

The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.

Magnus N, Meehan B, Garnier D, Hashemi M, Montermini L, Lee TH, Milsom C, Pawlinski R, Ohlfest J, Anderson M, Mackman N, Rak J.

Biochem Biophys Res Commun. 2014 Nov 14;454(2):262-8. Epub 2014 Oct 23.

PMID:
25450387
11.

Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells.

Lee TH, Chennakrishnaiah S, Audemard E, Montermini L, Meehan B, Rak J.

Biochem Biophys Res Commun. 2014 Aug 22;451(2):295-301. doi: 10.1016/j.bbrc.2014.07.109. Epub 2014 Jul 30.

PMID:
25086355
12.

Impact of host ageing on the metastatic phenotype.

Meehan B, Dombrovsky A, Lau K, Lai T, Magnus N, Montermini L, Rak J.

Mech Ageing Dev. 2013 Mar;134(3-4):118-29. doi: 10.1016/j.mad.2013.02.001. Epub 2013 Feb 10.

PMID:
23403123
13.

Diversity of ARSACS mutations in French-Canadians.

Thiffault I, Dicaire MJ, Tetreault M, Huang KN, Demers-Lamarche J, Bernard G, Duquette A, Larivière R, Gehring K, Montpetit A, McPherson PS, Richter A, Montermini L, Mercier J, Mitchell GA, Dupré N, Prévost C, Bouchard JP, Mathieu J, Brais B.

Can J Neurol Sci. 2013 Jan;40(1):61-6.

PMID:
23250129
14.

Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor.

Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T, Rak J.

J Biol Chem. 2012 Dec 21;287(52):43565-72. doi: 10.1074/jbc.M112.401760. Epub 2012 Nov 1.

15.

Oncogenic extracellular vesicles in brain tumor progression.

D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J.

Front Physiol. 2012 Jul 24;3:294. doi: 10.3389/fphys.2012.00294. eCollection 2012.

16.

Modulation of Lgl1 by steroid, retinoic acid, and vitamin D models complex transcriptional regulation during alveolarization.

Nadeau K, Montermini L, Mandeville I, Xu M, Weiss ST, Sweezey NB, Kaplan F.

Pediatr Res. 2010 Apr;67(4):375-81. doi: 10.1203/PDR.0b013e3181d23656.

17.

Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription.

Sakamoto N, Ohshima K, Montermini L, Pandolfo M, Wells RD.

J Biol Chem. 2001 Jul 20;276(29):27171-7. Epub 2001 May 4.

18.

GGA*TCC-interrupted triplets in long GAA*TTC repeats inhibit the formation of triplex and sticky DNA structures, alleviate transcription inhibition, and reduce genetic instabilities.

Sakamoto N, Larson JE, Iyer RR, Montermini L, Pandolfo M, Wells RD.

J Biol Chem. 2001 Jul 20;276(29):27178-87. Epub 2001 Apr 26.

19.

A nonpathogenic GAAGGA repeat in the Friedreich gene: implications for pathogenesis.

Ohshima K, Sakamoto N, Labuda M, Poirier J, Moseley ML, Montermini L, Ranum LP, Wells RD, Pandolfo M.

Neurology. 1999 Nov 10;53(8):1854-7.

PMID:
10563639
20.

Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes.

Cossée M, Dürr A, Schmitt M, Dahl N, Trouillas P, Allinson P, Kostrzewa M, Nivelon-Chevallier A, Gustavson KH, Kohlschütter A, Müller U, Mandel JL, Brice A, Koenig M, Cavalcanti F, Tammaro A, De Michele G, Filla A, Cocozza S, Labuda M, Montermini L, Poirier J, Pandolfo M.

Ann Neurol. 1999 Feb;45(2):200-6.

PMID:
9989622
21.

Expression of bovine leukemia virus ENV glycoprotein in insect cells by recombinant baculovirus.

Russo S, Montermini L, Berkovitz-Siman-Tov R, Ponti W, Poli G.

FEBS Lett. 1998 Sep 25;436(1):11-6.

22.

Prenatal diagnosis of Friedreich ataxia.

Pandolfo M, Montermini L.

Prenat Diagn. 1998 Aug;18(8):831-3. Review. No abstract available.

PMID:
9742572
23.

Molecular genetics of the hereditary ataxias.

Pandolfo M, Montermini L.

Adv Genet. 1998;38:31-68. Review.

PMID:
9677705
24.
25.

Friedreich's ataxia GAA repeat expansion in patients with recessive or sporadic ataxia.

Geschwind DH, Perlman S, Grody WW, Telatar M, Montermini L, Pandolfo M, Gatti RA.

Neurology. 1997 Oct;49(4):1004-9.

PMID:
9339680
26.

Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.

Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P, Authier FJ, Dürr A, Mandel JL, Vescovi A, Pandolfo M, Koenig M.

Hum Mol Genet. 1997 Oct;6(11):1771-80.

PMID:
9302253
27.

Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system.

Montermini L, Kish SJ, Jiralerspong S, Lamarche JB, Pandolfo M.

Neurology. 1997 Aug;49(2):606-10.

PMID:
9270608
28.

The Friedreich ataxia GAA triplet repeat: premutation and normal alleles.

Montermini L, Andermann E, Labuda M, Richter A, Pandolfo M, Cavalcanti F, Pianese L, Iodice L, Farina G, Monticelli A, Turano M, Filla A, De Michele G, Cocozza S.

Hum Mol Genet. 1997 Aug;6(8):1261-6.

PMID:
9259271
29.

Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.

Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J.

Science. 1997 Jun 13;276(5319):1709-12.

30.

Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion.

Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castellotti B, Mercier J, Poirier J, Capozzoli F, Bouchard JP, Lemieux B, Mathieu J, Vanasse M, Seni MH, Graham G, Andermann F, Andermann E, Melançon SB, Keats BJ, Di Donato S, Pandolfo M.

Ann Neurol. 1997 May;41(5):675-82.

PMID:
9153531
31.

Frataxin fracas.

Cossée M, Campuzano V, Koutnikova H, Fischbeck K, Mandel JL, Koenig M, Bidichandani SI, Patel PI, Moltè MD, Cañizares J, De Frutos R, Pianese L, Cavalcanti F, Monticelli A, Cocozza S, Montermini L, Pandolfo M.

Nat Genet. 1997 Apr;15(4):337-8. No abstract available.

PMID:
9090376
32.

Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo.

Jiralerspong S, Liu Y, Montermini L, Stifani S, Pandolfo M.

Neurobiol Dis. 1997;4(2):103-13.

PMID:
9331900
33.

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.

Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M.

Science. 1996 Mar 8;271(5254):1423-7.

PMID:
8596916
34.

Evidence for a common origin of most Friedreich ataxia chromosomes in the Spanish population.

Monrós E, Cañizares J, Moltó MD, Rodius F, Montermini L, Cossée M, Martínez F, Prieto F, de Frutos R, Koenig M, Pandolfo M, Bertranpetit J, Palau F.

Eur J Hum Genet. 1996;4(4):191-8.

PMID:
8875184
35.

The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13.

Montermini L, Rodius F, Pianese L, Moltò MD, Cossée M, Campuzano V, Cavalcanti F, Monticelli A, Palau F, Gyapay G, et al.

Am J Hum Genet. 1995 Nov;57(5):1061-7. Erratum in: Am J Hum Genet 1995 Dec;57(6):1520.

36.

Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations.

Verderio E, Cavadini P, Montermini L, Wang H, Lamantea E, Finocchiaro G, DiDonato S, Gellera C, Taroni F.

Hum Mol Genet. 1995 Jan;4(1):19-29.

PMID:
7711730
37.

Assignment of the human carnitine palmitoyltransferase II gene (CPT1) to chromosome 1p32.

Gellera C, Verderio E, Floridia G, Finocchiaro G, Montermini L, Cavadini P, Zuffardi O, Taroni F.

Genomics. 1994 Nov 1;24(1):195-7. No abstract available.

PMID:
7896283
38.

Identification of 5' regulatory regions of the human carnitine palmitoyltransferase II gene.

Montermini L, Wang H, Verderio E, Taroni F, DiDonato S, Finocchiaro G.

Biochim Biophys Acta. 1994 Sep 13;1219(1):237-40.

PMID:
8086471
39.

Molecular heterogeneity of beta-ETF deficiency in glutaric aciduria type II.

Colombo I, DiDonato S, Volta M, Gellera C, Garavaglia B, Montermini L, Yamaguchi S, Goodman SI, Frerman FE, Finocchiaro G.

Prog Clin Biol Res. 1992;375:561-6. No abstract available.

PMID:
1438399

Supplemental Content

Loading ...
Support Center